Economic Evaluation of Heart Failure Management in Colombian Clinics

AstraZeneca300 enrolled

Overview

Cost effectiveness analysis of local management of patients diagnosed with heart failure disease compared with an ideal guideline-based management.

Study Type

OBSERVATIONAL

Enrollment

300

Conditions

Heart Failure Asthma

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Asthma moderate to severe.

Outcomes

Primary Outcomes

To determine cost-effectiveness of Heart Failure management in 3 Heart-specialized clinics in Bogotá Colombia

Time frame: 12 months

Incremental cost-effectiveness ratio from using Symbicort as symbicort as Maintenance and Reliever Therapy (SMART) when compared with its competitive alternatives

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.